Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) |
78637-1 |
BPS Bioscience |
100 µl |
EUR 795 |
Description: The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike corresponding to the initial strain (Genbank Accession #QHD43416.1) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene; therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 in a Biosafety Level 2 facility.The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) has been validated for use with target cells Vero-E6, Calu-3, and ACE2-HEK293 (BPS Bioscience #79951). Spike VSV Delta G are preferred for use in cells such as Vero-E6 and Calu-3.The infectivity of VSV-Delta G pseudotypes is restricted to a single round of replication, therefore the pseudotypes can be handled using BSL-2 containment practices. |
Human IgG antibody Laboratories manufactures the dsred vsv spike protein reagents distributed by Genprice. The Dsred Vsv Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Dsred products are available in stock. Specificity: Dsred Category: Vsv Group: Spike Protein
VSV-G antibody |
Fitzgerald |
100 ug |
EUR 461 |
|
Description: Affinity purified Rabbit polyclonal VSV-G antibody |
Monoclonal Anti-Vesicular Stomatitis matrix protein (VSV-M, Indiana) IgG |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) |
BPS Bioscience |
100 µl |
EUR 795 |
Description: The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1; with D614G mutation) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene; therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 D614G variant in a Biosafety Level 2 facility.The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) has been validated for use with target cells Vero-E6 and ACE2-HEK293 (BPS Bioscience #79951). Spike VSV Delta G is preferred over lentiviral-based spike pseudoviruses for use in cells such as Vero-E6 parental cells. |
Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) |
BPS Bioscience |
500 µl x 2 |
EUR 3995 |
Description: The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1; with D614G mutation) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene; therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 D614G variant in a Biosafety Level 2 facility.The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) has been validated for use with target cells Vero-E6 and ACE2-HEK293 (BPS Bioscience #79951). Spike VSV Delta G is preferred over lentiviral-based spike pseudoviruses for use in cells such as Vero-E6 parental cells. |
Human SARS-CoV-2 Spike Protein IgG ELISA Kit |
Abbexa |
100 µg |
EUR 593.75 |
Human SARS-CoV-2 Spike Protein S1 IgG (S1-IgG) ELISA Kit |
Sunlong |
96 Tests |
EUR 468 |
|
Spike Protein information
SARS-CoV Spike Protein |
abx060655-1mg |
Abbexa |
1 mg |
EUR 2030.4 |
|
SARS-CoV Spike Protein |
abx060655-100g |
Abbexa |
100 µg |
Ask for price |
SARS-CoV Spike Protein |
abx060655-10g |
Abbexa |
10 µg |
EUR 1962.5 |
SARS-CoV Spike Protein |
abx060655-50g |
Abbexa |
50 µg |
Ask for price |
SARS-CoV Spike Protein |
abx060656-100g |
Abbexa |
100 µg |
Ask for price |
SARS-CoV Spike Protein |
abx060656-10g |
Abbexa |
10 µg |
EUR 1962.5 |
SARS-CoV Spike Protein |
abx060656-50g |
Abbexa |
50 µg |
Ask for price |
SARS-CoV Spike Protein |
abx060657-100g |
Abbexa |
100 µg |
Ask for price |
SARS-CoV Spike Protein |
abx060657-10g |
Abbexa |
10 µg |
EUR 1962.5 |
SARS-CoV Spike Protein |
abx060657-50g |
Abbexa |
50 µg |
Ask for price |
Anti-SARS Spike Protein |
18950 |
Genovis AB |
100ul |
EUR 551 |
Anti-SARS Spike Protein |
18951 |
Genovis AB |
100ul |
EUR 551 |
Anti-SARS Spike Protein |
18952 |
Genovis AB |
100ul |
EUR 551 |